{"TAP1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TAP1"}, "LIF": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "LIF"}, "PMAIP1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PMAIP1"}, "SUMO1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SUMO1"}, "PLK3": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PLK3"}, "FBXO11": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "FBXO11"}, "PIDD": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PIDD"}, "CASP10": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CASP10"}, "HIPK2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "HIPK2"}, "RB1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "RB1"}, "FDXR": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "FDXR"}, "RFWD2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "RFWD2"}, "BDNF": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "BDNF"}, "MDM2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MDM2"}, "PERP": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PERP"}, "CAV1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CAV1"}, "SMG1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SMG1"}, "GADD45A": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "GADD45A"}, "GRK5": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "GRK5"}, "DDIT4": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "DDIT4"}, "PRKAG1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PRKAG1"}, "CSNK1D": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CSNK1D"}, "CSNK1E": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CSNK1E"}, "SETD7": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SETD7"}, "DYRK1A": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "DYRK1A"}, "MYC": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MYC"}, "EDN2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "EDN2"}, "TP53AIP1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TP53AIP1"}, "BRCA1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "BRCA1"}, "TYRP1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TYRP1"}, "SH2D1A": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SH2D1A"}, "VRK1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "VRK1"}, "BARD1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "BARD1"}, "WRN": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "WRN"}, "SP1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SP1"}, "PRMT1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PRMT1"}, "CTSD": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CTSD"}, "PRMT5": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PRMT5"}, "CSNK1G2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CSNK1G2"}, "CSNK1G3": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CSNK1G3"}, "CSNK1G1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CSNK1G1"}, "SNAI2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SNAI2"}, "PMS2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PMS2"}, "SERPINB5": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SERPINB5"}, "CSNK2A1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CSNK2A1"}, "STK17A": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "STK17A"}, "KAT8": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "KAT8"}, "MAPK14": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MAPK14"}, "CCNG1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CCNG1"}, "PPP2CA": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PPP2CA"}, "MAX": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MAX"}, "PPP2CB": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PPP2CB"}, "KAT5": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "KAT5"}, "GSK3B": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "GSK3B"}, "SFN": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SFN"}, "PTEN": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PTEN"}, "ZNF274": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "ZNF274"}, "APC": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "APC"}, "SCN3B": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SCN3B"}, "CCNK": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CCNK"}, "VDR": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "VDR"}, "RPS27L": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "RPS27L"}, "NUAK1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "NUAK1"}, "CDKN1A": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CDKN1A"}, "MAPK13": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MAPK13"}, "C12orf5": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "C12orf5"}, "UBE2D1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "UBE2D1"}, "EP400": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "EP400"}, "NDRG1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "NDRG1"}, "MAPKAPK5": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MAPKAPK5"}, "SERPINE1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SERPINE1"}, "TGFA": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TGFA"}, "CABIN1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CABIN1"}, "CDK1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CDK1"}, "FOS": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "FOS"}, "JUN": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "JUN"}, "PPM1J": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PPM1J"}, "TRIAP1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TRIAP1"}, "PRKCA": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PRKCA"}, "PCBP4": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PCBP4"}, "RRM2B": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "RRM2B"}, "CX3CL1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CX3CL1"}, "PRKACA": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PRKACA"}, "GDF15": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "GDF15"}, "CHEK2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CHEK2"}, "CHEK1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CHEK1"}, "TTC5": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TTC5"}, "SIRT1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SIRT1"}, "PRKAB2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PRKAB2"}, "PRKAB1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PRKAB1"}, "RNF144B": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "RNF144B"}, "TP53I3": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TP53I3"}, "IGFBP3": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "IGFBP3"}, "TP53INP1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TP53INP1"}, "SMYD2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SMYD2"}, "SKP2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SKP2"}, "AFP": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "AFP"}, "HIC1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "HIC1"}, "TP53": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   ... to blast crisis requires other molecular changes. Common secondary abnormalities include mutations in TP53, RB, and p16/INK4A, or overexpression of genes such as EVI1. Additional chromosome translocations ...\n  "}, "gene": "TP53"}, "CSNK1A1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CSNK1A1"}, "TAF1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TAF1"}, "GPX1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "GPX1"}, "HTT": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "HTT"}, "PRDM1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PRDM1"}, "SORT1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SORT1"}, "CREBBP": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CREBBP"}, "YY1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "YY1"}, "SESN1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SESN1"}, "ATM": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "ATM"}, "EPHA2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "EPHA2"}, "PRKDC": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PRKDC"}, "TNFRSF10C": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TNFRSF10C"}, "TNFRSF10B": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TNFRSF10B"}, "TNFRSF10A": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TNFRSF10A"}, "DYRK2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "DYRK2"}, "ATR": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "ATR"}, "MAPK11": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MAPK11"}, "MAPK12": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MAPK12"}, "TNFRSF10D": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TNFRSF10D"}, "TP53RK": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TP53RK"}, "TSC2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TSC2"}, "NEDD8": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "NEDD8"}, "TP63": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TP63"}, "SIK1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SIK1"}, "BTG2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "BTG2"}, "CD82": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CD82"}, "MAPK3": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MAPK3"}, "MAPK1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MAPK1"}, "PML": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PML"}, "MAPK8": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MAPK8"}, "MAPK9": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MAPK9"}, "DUSP1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "DUSP1"}, "MSH2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MSH2"}, "APAF1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "APAF1"}, "S100A2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "S100A2"}, "CASP6": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CASP6"}, "IGBP1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "IGBP1"}, "H1F0": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "H1F0"}, "BNIP3L": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "BNIP3L"}, "EGFR": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "EGFR"}, "HMGA2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "HMGA2"}, "HMGA1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "HMGA1"}, "DUSP5": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "DUSP5"}, "BAX": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "BAX"}, "HIST1H1D": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "HIST1H1D"}, "HIST1H1E": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "HIST1H1E"}, "EP300": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "EP300"}, "HIST1H1A": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "HIST1H1A"}, "HIST1H1B": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "HIST1H1B"}, "HIST1H1C": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "HIST1H1C"}, "BDKRB2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "BDKRB2"}, "IRF5": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "IRF5"}, "HIRA": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "HIRA"}, "EIF2AK2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "EIF2AK2"}, "TP73": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TP73"}, "CARM1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CARM1"}, "MET": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MET"}, "CDK2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CDK2"}, "SPP1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SPP1"}, "CDK5": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CDK5"}, "CDK7": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CDK7"}, "CDK9": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CDK9"}, "STEAP3": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "STEAP3"}, "MAP4K4": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MAP4K4"}, "HMGB1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "HMGB1"}, "VCAN": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "VCAN"}, "PRKAA2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PRKAA2"}, "PRKAA1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PRKAA1"}, "USP7": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "USP7"}, "HSPA1A": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "HSPA1A"}, "NGFR": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "NGFR"}, "NLRC4": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "NLRC4"}, "TRIM28": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TRIM28"}, "BBC3": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "BBC3"}, "UBN1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "UBN1"}, "RCHY1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "RCHY1"}, "BCL2L14": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "BCL2L14"}, "CCNA2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CCNA2"}, "FAS": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "FAS"}, "BID": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "BID"}, "MLH1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MLH1"}, "MAPKAPK2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MAPKAPK2"}, "KAT2B": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "KAT2B"}, "AURKA": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "AURKA"}, "AURKB": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "AURKB"}, "PYCARD": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PYCARD"}, "DAPK3": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "DAPK3"}, "ASF1A": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "ASF1A"}, "DAPK1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "DAPK1"}, "PCNA": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PCNA"}, "TRAF6": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "TRAF6"}, "COL18A1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "COL18A1"}, "PRKCD": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PRKCD"}, "E4F1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "E4F1"}, "AIFM2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "AIFM2"}, "STK11": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "STK11"}, "HGF": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "HGF"}, "DDB2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "DDB2"}, "ARID3A": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "ARID3A"}, "CCNB1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CCNB1"}, "PPP1R13L": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "PPP1R13L"}, "SETD8": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "SETD8"}, "CASP1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "CASP1"}, "DKK1": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "DKK1"}, "RGCC": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "RGCC"}, "BCL6": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "BCL6"}, "MMP2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "MMP2"}, "ATF3": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "ATF3"}, "BCL2": {"H00004": {"Category": "   Cancer\n  ", "Pathway": "hsa05220  Chronic myeloid leukemia\n  ", "Name": "   Chronic myeloid leukemia (CML)\n  ", "Drug": "   Imatinib mesylate (Gleevec) [DG:DG00710]\nNilotinib [DG:DG00716]\nDasatinib [DG:DG00714]\n  ", "Description": "   Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP) ...\n  "}, "gene": "BCL2"}}